Key facts
- Notable investors include InnoPinnacle.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Zhiyao Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Zhiyao Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zhiyao Bio
Manufacturer of a biopharmaceutical drug intended to advance the clinical research of novel postoperative analgesics. The company offers proprietary modified innovative drug candidates, a focused R&D pipeline, and a commitment to safety and efficacy, enabling healthcare providers and postoperative care institutions to access more effective and safer pain management therapies.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 2022
- Website
- brightintel.cn/
- Ownership
- Privately Held (backing)
Zhiyao Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zhiyao Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zhiyao Bio in its N-PORT filings yet. We sweep new filings monthly.